Mounjaro 12,5 mg 1 pen
Eli Lilly
Eli Lilly
Overview
Mounjaro 12.5 mg Pen is a prescription injectable medicine from Eli Lilly containing tirzepatide, used in adults with type 2 diabetes as part of medical treatment for blood sugar management.
Key Benefits
Tirzepatide is a dual GIP and GLP-1 receptor agonist that supports improved blood sugar control in type 2 diabetes. May support weight management as part of an overall treatment plan. Contributes to metabolic regulation under medical supervision. Supplied as a pre-filled pen for once-weekly subcutaneous injection.
How to Use
Inject subcutaneously once weekly using the pre-filled pen, rotating injection sites between the abdomen, thigh, and upper arm. Dosage is determined and adjusted by the prescribing physician; use exactly as directed.
Active Ingredients
Tirzepatide.
Precautions
For use under medical supervision only, by prescription. Not indicated for type 1 diabetes or diabetic ketoacidosis. Not for use in case of hypersensitivity to tirzepatide or its excipients. Monitor for gastrointestinal side effects and for hypoglycemia, particularly when combined with insulin or sulfonylureas. Discuss any other medications with your doctor or pharmacist.
Storage
Store in a refrigerator, protected from light; do not freeze. Once in use, follow the storage period advised by your pharmacist. Keep out of reach of children.